MX2015011966A - Compuestos de resorcinol para uso dermatologico. - Google Patents

Compuestos de resorcinol para uso dermatologico.

Info

Publication number
MX2015011966A
MX2015011966A MX2015011966A MX2015011966A MX2015011966A MX 2015011966 A MX2015011966 A MX 2015011966A MX 2015011966 A MX2015011966 A MX 2015011966A MX 2015011966 A MX2015011966 A MX 2015011966A MX 2015011966 A MX2015011966 A MX 2015011966A
Authority
MX
Mexico
Prior art keywords
skin
dermatological use
resorcinol compounds
preventing
methods
Prior art date
Application number
MX2015011966A
Other languages
English (en)
Other versions
MX355430B (es
Inventor
Viktoria Kheifets
Andrew W Hinman
Dana Davis
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of MX2015011966A publication Critical patent/MX2015011966A/es
Publication of MX355430B publication Critical patent/MX355430B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A61K8/70Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine containing perfluoro groups, e.g. perfluoroethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/08Dihydroxy benzenes; Alkylated derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/17Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings containing other rings in addition to the six-membered aromatic rings, e.g. cyclohexylphenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • C07C39/367Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • C07C39/42Halogenated derivatives containing six-membered aromatic rings and other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/522Antioxidants; Radical scavengers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gerontology & Geriatric Medicine (AREA)

Abstract

La presente proporciona métodos y composiciones que contienen derivados de resorcinol para utilizarse en el tratamiento, regulación o prevención de una condición de la piel caracterizada por estrés oxidante o un proceso degenerativo. También se describen métodos para evitar, aclarar o reducir la aparición de discontinuidades visibles de la piel que resultan de la pigmentación de la piel, envejecimiento de la piel, u otros trastornos.
MX2015011966A 2013-03-08 2014-03-06 Compuestos de resorcinol para uso dermatologico. MX355430B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361775384P 2013-03-08 2013-03-08
PCT/US2014/021390 WO2014138471A2 (en) 2013-03-08 2014-03-06 Resorcinol compounds for dermatological use

Publications (2)

Publication Number Publication Date
MX2015011966A true MX2015011966A (es) 2016-04-07
MX355430B MX355430B (es) 2018-04-18

Family

ID=50424742

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015011966A MX355430B (es) 2013-03-08 2014-03-06 Compuestos de resorcinol para uso dermatologico.

Country Status (10)

Country Link
US (2) US10470986B2 (es)
EP (1) EP2964182B1 (es)
JP (1) JP6313791B2 (es)
CN (1) CN105142603B (es)
BR (1) BR112015021033B1 (es)
CA (2) CA3167320A1 (es)
EA (1) EA031098B1 (es)
MX (1) MX355430B (es)
WO (1) WO2014138471A2 (es)
ZA (1) ZA201506589B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019675B1 (ru) 2006-02-22 2014-05-30 Эдисон Фармасьютикалз, Инк. Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q
MX2010004622A (es) 2007-11-06 2010-05-20 Edison Pharmaceuticals Inc Derivados de 4-(p-quinonil)-2-hidroxibutanamida para tratamiento de enfermedades mitocondriales.
WO2010030607A1 (en) 2008-09-10 2010-03-18 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
CA2741767C (en) 2008-10-28 2017-09-12 Kieron E. Wesson Process for the production of alpha-tocotrienol and derivatives
DK2424495T3 (en) 2009-04-28 2018-04-30 Bioelectron Tech Corp TREATMENT OF LEVERS HEREDIC OPTICAL NEUROPATHY AND DOMINANT OPTICAL ATROPHY WITH TOCOTRIENOL QUINONES
JP6313791B2 (ja) 2013-03-08 2018-04-18 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚科学的使用のためのレゾルシノール化合物
RU2770091C2 (ru) 2014-12-16 2022-04-14 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Полиморфные и аморфные формы (r)-2-гидрокси-2-метил-4-(2,4,5-триметил-3,6-диоксоциклогекса-1,4-диенил)бутанамида
EP3390377A1 (en) 2015-12-16 2018-10-24 BioElectron Technology Corporation Improved methods for enriching alpha-tocotrienol from mixed tocol compositions
CN109310599B (zh) 2016-06-15 2023-01-13 联合利华知识产权控股有限公司 用于增强烷基取代的间苯二酚的透皮递送的方法和化妆品组合物
JP2018083799A (ja) 2016-11-15 2018-05-31 バイオエレクトロン テクノロジー コーポレイション 2−置換アミノ−ナフト[1,2−d]イミダゾール−5−オン化合物またはその製薬学上許容される塩
CA3069345A1 (en) 2017-07-12 2019-01-17 Unilever Plc Skin composition booster oil
US20210000707A1 (en) 2017-07-12 2021-01-07 Conopco, Inc., D/B/A Unilever Nanoemulsions with color stabilized actives
US11452693B2 (en) 2017-07-12 2022-09-27 Conopco, Inc. Freeze dried active composition and a system for using the same
EA202092461A1 (ru) 2018-05-23 2021-02-20 Юнилевер Н.В. Наноэмульсии и способ их получения
TN2021000075A1 (en) 2018-10-17 2023-01-05 Ptc Therapeutics Inc 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING α-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS
EP3876897B1 (en) 2018-11-09 2023-12-20 Unilever Global Ip Limited Red colorant free of cochineal red and compositions comprising the same
CN113557002B (zh) 2019-04-01 2023-11-24 联合利华知识产权控股有限公司 包含油连续纳米乳液的多重乳液及使用该乳液的方法
CN115297820A (zh) 2019-10-31 2022-11-04 联合利华知识产权控股有限公司 泡沫前体液体和泡沫清洁组合物
CN114867453A (zh) 2020-01-21 2022-08-05 联合利华知识产权控股有限公司 各向同性浓缩物和洗涤组合物
CA3164296A1 (en) 2020-01-21 2021-07-29 Douglas John Hiban Hydratable concentrated surfactant composition
EP4110274B1 (en) 2020-02-28 2023-08-09 Unilever IP Holdings B.V. High polyol wash composition
US11382847B2 (en) 2020-02-28 2022-07-12 Conopco, Inc. High polyol wash composition
US11523978B2 (en) 2020-03-27 2022-12-13 Conopco, Inc. Compositions comprising naturally derived preservatives
CA3171604A1 (en) 2020-03-27 2021-09-30 Kimberly DAY Compositions comprising naturally derived preservatives
WO2021234005A1 (en) 2020-05-22 2021-11-25 Unilever Ip Holdings B.V. A personal care composition
CA3179943A1 (en) 2020-06-04 2021-12-09 Unilever Global Ip Limited Naturally derived surfactant system with polyglycerol esters and compositions comprising the same
CA3179813A1 (en) 2020-06-04 2021-12-09 David Waters Naturally derived surfactant system and composition comprising the same
US20230255868A1 (en) 2020-06-30 2023-08-17 Conopco, Inc., D/B/A Unilever Sanitizing composition
CN111743799B (zh) * 2020-07-07 2023-01-10 台湾美联生物科技有限公司 纳米级固态脂质载体及制备方法和包含其的化妆品
US20230310292A1 (en) 2020-08-21 2023-10-05 Conopco, Inc., D/B/A Unilever Preservative systems and compositions comprising the same
BR112023005033A2 (pt) 2020-09-25 2023-04-18 Unilever Ip Holdings B V Composição antibacteriana e método de preparação de uma composição antibacteriana
JP2023545935A (ja) * 2020-09-25 2023-11-01 ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ 保湿抗菌組成物
US20230301883A1 (en) 2020-09-25 2023-09-28 Conopco, Inc., D/B/A Unilever Moisturizing antibacterial composition
CA3195392A1 (en) 2020-11-13 2022-05-19 Bivash Ranjan Dasgupta Wash composition
EP4243765A1 (en) 2020-11-13 2023-09-20 Unilever IP Holdings B.V. Stable wash composition
WO2022128801A1 (en) 2020-12-17 2022-06-23 Unilever Ip Holdings B.V. Styling composition
US20240197588A1 (en) 2021-04-21 2024-06-20 Conopco, Inc., D/B/A Unilever Antimicrobial composition
MX2023012992A (es) 2021-05-04 2023-11-15 Unilever Ip Holdings B V Composicion tensoactiva concentrada hidratable sustancialmente libre de isetionatos.
EP4362884A1 (en) 2021-07-02 2024-05-08 Unilever IP Holdings B.V. Ester comprising hydratable concentrated surfactant composition
EP4362883A1 (en) 2021-07-02 2024-05-08 Unilever IP Holdings B.V. Hydratable concentrated surfactant composition comprising a compound with a defined weight percent of oxygen
US11786486B2 (en) 2021-07-08 2023-10-17 Ptc Therapeutics, Inc. Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
CN118201583A (zh) 2021-11-01 2024-06-14 联合利华知识产权控股有限公司 清洁皂条及其组合物
WO2023227305A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Concentrated cleansing compositions
WO2023227304A1 (en) 2022-05-27 2023-11-30 Unilever Ip Holdings B.V. Concentrated conditioning compositions
WO2024002892A1 (en) 2022-06-29 2024-01-04 Unilever Ip Holdings B.V. Anti-acne composition
WO2024002646A1 (en) 2022-06-30 2024-01-04 Unilever Ip Holdings B.V. Stable wash composition with biodegradable thickener
WO2024002647A1 (en) 2022-06-30 2024-01-04 Unilever Ip Holdings B.V. Stable wash composition with unsaturated zwitterionic surfactant
WO2024002645A1 (en) 2022-06-30 2024-01-04 Unilever Ip Holdings B.V. Reduced palm kernel reliant wash composition
WO2024056587A1 (en) 2022-09-16 2024-03-21 Unilever Ip Holdings B.V. Self-foaming cleansing composition
WO2024056586A2 (en) 2022-09-16 2024-03-21 Unilever Ip Holdings B.V. Self-foaming cleansing composition
WO2024068056A1 (en) 2022-09-27 2024-04-04 Unilever Ip Holdings B.V. Mild wash composition with biodegradable thickener and enhanced microbiota impact
EP4356896A1 (en) 2022-10-18 2024-04-24 Unilever IP Holdings B.V. Composition comprising surfactant prepared with carbon from carbon capture
WO2024097166A1 (en) 2022-11-02 2024-05-10 Nutrition & Biosciences USA 4, Inc. Compositions comprising xanthan gum and crystalline alpha-1,3-glucan
WO2024120839A1 (en) 2022-12-07 2024-06-13 Unilever Ip Holdings B.V. Nanoemuslions of plant based jelly
WO2024126196A1 (en) 2022-12-16 2024-06-20 Unilever Ip Holdings B.V. Branched fatty acyl isethionates

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526179A (en) 1983-01-28 1985-07-02 Leonard Salesky Digital apical foramen locating apparatus
JPS6127909A (ja) 1984-07-17 1986-02-07 Shiseido Co Ltd 皮膚外用剤
JPH0651619B2 (ja) 1988-05-09 1994-07-06 株式会社クラレ 美白剤
JP2969363B2 (ja) * 1990-03-30 1999-11-02 株式会社ナリス化粧品 チロシナーゼ活性抑制剤、抗酸化剤
JP2896815B2 (ja) 1991-01-29 1999-05-31 有限会社野々川商事 化粧料
FR2679133B1 (fr) 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.
US5399785A (en) * 1992-08-05 1995-03-21 Nippon Paint Co., Ltd. Tyrosinase activity inhibitor
JPH0656641A (ja) * 1992-08-05 1994-03-01 Nippon Paint Co Ltd 化粧料
JP3284612B2 (ja) * 1992-09-11 2002-05-20 ソニー株式会社 半導体レーザーの製造方法
FR2704428B1 (fr) 1993-04-29 1995-06-09 Oreal Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.
JPH0725742A (ja) 1993-07-15 1995-01-27 Kao Corp 美白化粧料
JPH0887989A (ja) 1994-09-19 1996-04-02 Ushio Inc 誘電体バリア放電ランプ
JPH10265322A (ja) 1997-03-19 1998-10-06 Shiseido Co Ltd 皮膚外用剤
BR9803596A (pt) 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US5980904A (en) 1998-11-18 1999-11-09 Amway Corporation Skin whitening composition containing bearberry extract and a reducing agent
US6828460B2 (en) 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
JP4004182B2 (ja) 1999-05-24 2007-11-07 ポーラ化成工業株式会社 乳化組成物
JP4015781B2 (ja) 1999-06-28 2007-11-28 ポーラ化成工業株式会社 乳化組成物
JP4015792B2 (ja) 1999-12-10 2007-11-28 株式会社コーセー 美白剤及びそれを有効成分として含有する皮膚外用剤
JP2001181173A (ja) 1999-12-27 2001-07-03 Kose Corp 美白外用剤
EP1134207A1 (en) 2000-03-15 2001-09-19 Pfizer Products Inc. Process for preparing resorcinol derivatives
US6863897B2 (en) 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
US6858217B2 (en) 2002-03-22 2005-02-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of terpenoids in cosmetic compositions
US6852310B2 (en) 2002-08-23 2005-02-08 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Skin lightening agents, compositions and methods
RU2240343C2 (ru) * 2002-09-17 2004-11-20 Эль-Регистан Галина Ивановна Способ производства солода
GB0306088D0 (en) 2002-12-09 2003-04-23 Unilever Plc Process for the preparation of a cosmetic active
GB0306081D0 (en) 2002-12-09 2003-04-23 Unilever Plc Process for the preparation of a cosmetic active
US20040109832A1 (en) 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
US7524485B2 (en) 2002-12-12 2009-04-28 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
CA2513949A1 (en) 2003-02-03 2004-08-19 Warner-Lambert Company Llc Improved formulation for skin-lightening agents
GB0314531D0 (en) 2003-03-11 2003-07-30 Unilever Plc Process for the preparation of a cosmetic active
KR101038184B1 (ko) 2003-07-08 2011-06-01 유니레버 엔.브이. 화장 활성물질의 제조 방법
US7300646B2 (en) 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
US20060210497A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
DE102007038097A1 (de) 2007-08-13 2009-02-19 Merck Patent Gmbh Tyrosinaseinhibitoren
JP6313791B2 (ja) 2013-03-08 2018-04-18 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚科学的使用のためのレゾルシノール化合物

Also Published As

Publication number Publication date
MX355430B (es) 2018-04-18
JP2016510757A (ja) 2016-04-11
CN105142603B (zh) 2018-10-19
JP6313791B2 (ja) 2018-04-18
BR112015021033A2 (pt) 2017-07-18
CA3167320A1 (en) 2014-09-12
US20140256830A1 (en) 2014-09-11
EA031098B1 (ru) 2018-11-30
EP2964182B1 (en) 2018-02-14
WO2014138471A2 (en) 2014-09-12
BR112015021033B1 (pt) 2020-08-04
CA2902506A1 (en) 2014-09-12
EA201591367A1 (ru) 2016-02-29
US20160000669A1 (en) 2016-01-07
CN105142603A (zh) 2015-12-09
WO2014138471A3 (en) 2014-12-04
ZA201506589B (en) 2017-01-25
BR112015021033A8 (pt) 2019-11-26
EP2964182A2 (en) 2016-01-13
US10470986B2 (en) 2019-11-12

Similar Documents

Publication Publication Date Title
MX2015011966A (es) Compuestos de resorcinol para uso dermatologico.
MX2017013562A (es) Reguladores de microbioma y usos relacionados de los mismos.
EP3354257A4 (en) COMPOSITION FOR IMPROVING SKIN AND PREVENTING HAIR LOSS WITH EXTRACELLULAR VESICLES FROM PLANT EXTRACTS
WO2015073587A3 (en) Synthetic membrane-receiver complexes
MX2018005829A (es) Composiciones para tratar el cabello.
MX359327B (es) Composiciones y sus usos para tratar y prevenir la enfermedad de huntington.
MY202135A (en) Uses of neuroactive compounds
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
EP3538119A4 (en) COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES AND MAINTAINING HEALTHY SKIN
MX362488B (es) Composiciones y metodos para tratar la perdida del cabello y retrasar el envejecimiento de la piel.
MY196718A (en) Composition for skin whitening comprising b-mangostin as effective ingredient
EP3352755A4 (en) Novel Compositions and Methods for the Treatment and Prevention of Skin Diseases
EP2982678A4 (en) NOVEL PHYTOSPINGOSIN-1-PHOSPHATE DERIVATIVE, PREPARATION METHOD THEREOF, AND COMPOSITION FOR PREVENTING AND TREATING HAIR LOSS OR FOR STIMULATING HAIR GROWTH COMPRISING THE SAME
WO2014116556A3 (en) Compositions and methods for regulating thermogenesis and muscle inflammation using metrnl and metrn
EP3074026A4 (en) Composition, system and method for treating skin
MX2014009750A (es) Composiciones antifungicas para el tratamiento de piel y uñas.
MX359181B (es) Hidrolizado de colágeno y uso del mismo.
WO2014172608A3 (en) Parthenolide derivatives and their modulation of processes controlled by regulated translation
EP3137082A4 (en) Methods to treat, prevent, and improve skin conditions
EP3060259A4 (en) Methods of treating or preventing vascular diseases of the retina
MX2016016407A (es) Composiciones biofotonicas termoestables y usos de las mismas.
WO2019016597A3 (en) SYNTHETIC PROTEINS AND THEIR THERAPEUTIC USES
EP3190887A4 (en) Methods for treating and preventing ocular diseases, disorders, and conditions with melanin and melanin analogs, precursors, and derivatives
WO2014194053A3 (en) Carbohydrate compounds for nutritional and therapeutic use
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.

Legal Events

Date Code Title Description
FG Grant or registration